
Bispecific T Cell Engager (Bite) - Recombinant Fusion Protein, >95% Purity | Targeted Cancer Antibody Therapy, T-cell Activation
Get Latest Price
In Stock
Product Specifications
| Product Type | Antibody therapy |
| Structure | Bispecific |
| Target | Cancer cells |
| Mechanism | T-cell activation |
| Purity | >95% |
| Formulation | Liquid |
| Usage | Treats various cancers by redirecting cytotoxic T cells to target tumor cells via specific antigens such as CD19, EpCAM, Her2/neu, EGFR, CEA, EphA2, CD33, and MCSP. |
| Features | Targeted therapy, Cancer treatment, Improved efficacy, Enhanced safety |
Product Overview
Key Features
Company Details
Focusing on a customer-centric approach, Creative Biolabs has a pan-India presence and caters to a huge consumer base throughout the country. Get Others from Creative Biolabs at Trade India quality-assured services.
Business Type
Manufacturer, Service Provider, Supplier
Employee Count
1
Establishment
2004
Working Days
Monday To Sunday
More Products From This Seller
Seller Details
New York, New York
Name
Mr. Bella Smith
Address
SUITE 203, 17 Ramsey Road, Shirley, New York, New York, 11967, United States
Report incorrect details
















